Neurocrine Biosciences Inc.

11/04/2024 | Press release | Distributed by Public on 11/04/2024 07:58

Neurocrine Biosciences Presents Breadth of Data Demonstrating Holistic Improvements Over Time in Patients With Tardive Dyskinesia Following Treatment With INGREZZA®[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.